Septal myectomy after previous septal artery ablation in hypertrophic cardiomyopathy
Andrew W ElBardissi1, Jospeh A Dearani, Rick A Nishimura
1Division of Cardiovascular Surgery, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
Insights
Septal artery ablation failure in hypertrophic cardiomyopathy patients necessitates septal myectomy, which effectively reduces left ventricular outflow tract gradient and improves symptoms, despite increased risks. This procedure offers significant relief for patients unresponsive to ablation.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Septal artery ablation is a treatment for hypertrophic cardiomyopathy (HCM).
- Some patients do not benefit from septal artery ablation and require further intervention.
- Septal myectomy is a surgical option for HCM, but its efficacy after failed ablation is less understood.
Purpose of the Study:
- To review the institutional experience with septal myectomy after failed septal artery ablation.
- To identify reasons for septal artery ablation failure.
- To evaluate the outcomes of septal myectomy in patients with prior ablation.
Main Methods:
- Retrospective analysis of 16 patients who underwent septal myectomy after septal artery ablation.
- Comparison with a control group of 120 patients who underwent septal artery ablation.
- Review of angiograms, echocardiograms, and clinical data to assess ablation failure and myectomy outcomes.
Main Results:
- Septal myectomy significantly reduced left ventricular outflow tract (LVOT) gradient and mitral regurgitation post-procedure.
- All surviving patients experienced symptom improvement at follow-up.
- Patients undergoing myectomy after ablation had higher operative mortality and morbidity compared to controls.
Conclusions:
- Septal myectomy is effective in improving LVOT gradient and relieving symptoms in patients with failed septal artery ablation.
- However, this patient group faces a higher risk of complications and mortality.
- Careful patient selection and management are crucial for septal myectomy after ablation.
Objective:
To review our institution's experience with patients who failed to benefit from septal artery ablation, which necessitated subsequent septal myectomy, and to examine reasons for ablation failure and outcome of myectomy after ablation.
Participants And Methods:
Of 550 patients who underwent septal myectomy at Mayo Clinic Rochester between January 1, 1999, and December 31, 2006, 16 (3%) had had a total of 22 previous septal artery ablations. This subset of 16 patients was analyzed and compared with a reference group of 120 patients whose septal artery ablations were performed at our institution during this period. Angiograms obtained during septal ablation were available for 13 (81%) of 16 patients in this series and were reviewed by 2 interventional cardiologists (R.A.N. and S.R.O.). These cardiologists also reviewed preoperative and postoperative echocardiography data, hospital course, and follow-up data to compile a list of characteristics that could have contributed to failed ablation.
Results:
The median age of the patients at operation was 65 years (interquartile range [IQR], 52-72 years), and interval between ablation and myectomy was 409 days (IQR, 162-568 days). Angiograms revealed 2 failed procedures secondary to technical error. One patient had a relatively large first septal perforator with a large resting gradient. In 10 patients no septal perforators supplying the proximal septum were identified. Postoperatively, mitral regurgitation decreased from 3.00 to 1.00 (P less than .001), and left ventricular outflow tract gradient decreased from 75 mm Hg to 0 mm Hg (IQR, 0-29 mm Hg; P less than .001). Two patients died after surgery: 1 patient developed multiple-organ system failure on postoperative day 7, and 1 patient developed arrhythmia on postoperative day 21. Patients with previous septal artery ablation were older (P=.04), were more likely to have preoperative permanent pacemakers or implantable cardioverter-defibrillators (P=.05), were more likely to require postoperative pacemaker placement (P less than .001), and had higher operative mortality (P less than .001) than control patients. Fourteen patients survived the early recovery phase; 9 were followed up at a median of 1.88 years (IQR, 306 days to 3.3 years). All patients' symptoms improved. Median gradient of the left ventricular outflow tract was 13 mm Hg (IQR, 0-15 mm Hg) at follow-up with mild to moderate (1.6) mitral regurgitation.
Conclusion:
Septal myectomy performed after failed ablation improves gradient and provides excellent relief of symptoms but is associated with a higher incidence of morbidity and mortality.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

